SE410969B - Forfarande for framstellning av nya alkylfenylbensopyranopyridiner - Google Patents
Forfarande for framstellning av nya alkylfenylbensopyranopyridinerInfo
- Publication number
- SE410969B SE410969B SE7404387A SE7404387A SE410969B SE 410969 B SE410969 B SE 410969B SE 7404387 A SE7404387 A SE 7404387A SE 7404387 A SE7404387 A SE 7404387A SE 410969 B SE410969 B SE 410969B
- Authority
- SE
- Sweden
- Prior art keywords
- alkylpenylbenzopyranopyridines
- procedure
- making new
- making
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
- C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
- C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34594273A | 1973-04-02 | 1973-04-02 | |
| US05/442,032 US3932432A (en) | 1973-04-02 | 1974-02-13 | Alkylphenyl benzopyranopyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE410969B true SE410969B (sv) | 1979-11-19 |
Family
ID=26994621
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7404387A SE410969B (sv) | 1973-04-02 | 1974-04-01 | Forfarande for framstellning av nya alkylfenylbensopyranopyridiner |
| SE7605758A SE425786B (sv) | 1973-04-02 | 1976-05-20 | Mellanprodukt for framstellning av alkylfenylbensopyranopyridiner |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7605758A SE425786B (sv) | 1973-04-02 | 1976-05-20 | Mellanprodukt for framstellning av alkylfenylbensopyranopyridiner |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3932432A (sv) |
| JP (1) | JPS5632995B2 (sv) |
| CA (1) | CA1020559A (sv) |
| CH (1) | CH593288A5 (sv) |
| DE (1) | DE2415698A1 (sv) |
| DK (1) | DK144656C (sv) |
| FI (1) | FI60711C (sv) |
| FR (1) | FR2223041B1 (sv) |
| GB (1) | GB1438423A (sv) |
| NL (1) | NL7404244A (sv) |
| NO (1) | NO139961C (sv) |
| PH (1) | PH10450A (sv) |
| SE (2) | SE410969B (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4247557A (en) * | 1976-08-04 | 1981-01-27 | Abbott Laboratories | Benzopyranopyridines as antiglaucoma agents |
| US4136183A (en) * | 1976-08-04 | 1979-01-23 | Abbott Laboratories | Benzopyranopyridines as antiglaucoma agents |
| JPS5392798A (en) * | 1977-01-21 | 1978-08-15 | Abbott Lab | 2*88substituted 100hydroxyy5*55 dimethyll1*2*3*44tetrahydroo5hh *1*benzopyrano*4*33c*pyridines |
| US4137232A (en) * | 1978-04-19 | 1979-01-30 | Abbott Laboratories | 2,8-Disubstituted-10-hydroxy-5,5-dimethyl-1,2,3,4-tetrahydro-5H -[1]benzopyrano[4,3-c]pyridine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3878219A (en) * | 1973-07-13 | 1975-04-15 | Abbott Lab | 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines |
-
1974
- 1974-02-13 US US05/442,032 patent/US3932432A/en not_active Expired - Lifetime
- 1974-03-26 FI FI920/74A patent/FI60711C/fi active
- 1974-03-28 NL NL7404244A patent/NL7404244A/xx not_active Application Discontinuation
- 1974-03-29 NO NO741141A patent/NO139961C/no unknown
- 1974-03-29 FR FR7411149A patent/FR2223041B1/fr not_active Expired
- 1974-04-01 SE SE7404387A patent/SE410969B/sv unknown
- 1974-04-01 GB GB1440674A patent/GB1438423A/en not_active Expired
- 1974-04-01 CA CA196,454A patent/CA1020559A/en not_active Expired
- 1974-04-01 PH PH15682A patent/PH10450A/en unknown
- 1974-04-01 DE DE2415698A patent/DE2415698A1/de not_active Ceased
- 1974-04-02 CH CH461874A patent/CH593288A5/xx not_active IP Right Cessation
- 1974-04-02 DK DK183374A patent/DK144656C/da not_active IP Right Cessation
- 1974-04-02 JP JP3671874A patent/JPS5632995B2/ja not_active Expired
-
1976
- 1976-05-20 SE SE7605758A patent/SE425786B/sv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US3932432A (en) | 1976-01-13 |
| GB1438423A (en) | 1976-06-09 |
| AU6664874A (en) | 1975-09-18 |
| NO741141L (no) | 1974-10-03 |
| CA1020559A (en) | 1977-11-08 |
| JPS5062999A (sv) | 1975-05-29 |
| JPS5632995B2 (sv) | 1981-07-31 |
| NL7404244A (sv) | 1974-10-04 |
| CH593288A5 (sv) | 1977-11-30 |
| PH10450A (en) | 1977-03-31 |
| FR2223041B1 (sv) | 1977-07-01 |
| SE7605758L (sv) | 1976-05-21 |
| NO139961B (no) | 1979-03-05 |
| NO139961C (no) | 1979-06-13 |
| DK144656B (da) | 1982-05-03 |
| FR2223041A1 (sv) | 1974-10-25 |
| DE2415698A1 (de) | 1974-10-10 |
| DK144656C (da) | 1982-10-04 |
| FI60711C (fi) | 1982-03-10 |
| SE425786B (sv) | 1982-11-08 |
| FI60711B (fi) | 1981-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE419981B (sv) | Forfarande for framstellning av 1alfa-hydroxi-vitamin d-derivat | |
| SE453667B (sv) | Forfarande for framstellning av polyeterimider | |
| SE402772B (sv) | Forfarande for framstellning av nya isotiocyanobensazoler | |
| SE7808959L (sv) | Forfarande for framstellning av dylenoxid | |
| SE420201B (sv) | Forfarande for framstellning av nya 7alfa-metoxicefalosporinderivat | |
| SE424994B (sv) | Forfarande for framstellning av nya pseudotrisackarider | |
| SE416731B (sv) | Forfarande for framstellning av nya penicilliner | |
| FI54604C (fi) | Foerfarande foer framstaellning av endokrint verksamma nya d-homosteroider | |
| SE424863B (sv) | Analogiforfarande for framstellning av nya isokinolinderivat | |
| SE400074B (sv) | Analogiforfarande for framstellning av nya tripeptider | |
| SE7709160L (sv) | Nya glycerolderivat | |
| SE405700B (sv) | Forfarande for forvermning av former | |
| SE430065B (sv) | Forfarande for framstellning av nya 7 alfa-metoxicefalosporinderivat | |
| SE7710418L (sv) | Forfarande for framstellning av nya heterocykliska foreningar | |
| SE420716B (sv) | Forfarande for framstellning av nya 2-aminometyl-4,6-diahalogenofenolderivat | |
| SE421129B (sv) | Forfarande for framstellning av poly-n-alkyl-iminoalaner | |
| SE411749B (sv) | Forfarande for framstellning av nya bensylaminer | |
| SE404801B (sv) | Forfaranden for framstellning av nya tiazolderivat | |
| SE401513B (sv) | Forfarande for framstellning an nya steroid-n-nitrosoforeningar | |
| FI55498C (fi) | Foerfarande foer framstaellning av hypoglycemiska pyridinkarboxamid-sulfonylureafoereningar | |
| SE384027B (sv) | Forfarande for framstellning av nya alfa-alkylsulfobensylpenicilliner | |
| SE410969B (sv) | Forfarande for framstellning av nya alkylfenylbensopyranopyridiner | |
| SE404361B (sv) | Forfarande for framstellning av nya 1-fenyl-3hydroxi-3-metyl-triazener | |
| SE401506B (sv) | Forfarande for framstellning av bifenylyletrar | |
| SE415975B (sv) | Forfarande for framstellning av nya bensylpyrimidiner |